-
*Masahiro TOHKIN
Department of Medicinal Safety Science, Graduate School of Pharmaceutical Sciences, Nagoya City University Division of Medicinal Safety Science, National Institute of Health Sciences
-
Nahoko KANIWA
Division of Medicinal Safety Science, National Institute of Health Sciences
-
Yoshiro SAITO
Division of Medicinal Safety Science, National Institute of Health Sciences
-
Emiko SUGIYAMA
Division of Medicinal Safety Science, National Institute of Health Sciences
-
Kouichi KUROSE
Division of Medicinal Safety Science, National Institute of Health Sciences
-
Jun NISHIKAWA
Division of Medicinal Safety Science, National Institute of Health Sciences
-
Ryuichi HASEGAWA
Division of Medicinal Safety Science, National Institute of Health Sciences
-
Michiko AIHARA
Department of Environmental Immunodermatology, Yokohama City University Graduate School of Medicine
-
Kayoko MATSUNAGA
Department of Dermatology, Fujita Health University School of Medicine
-
Masamichi ABE
Department of Dermatology, Fujita Health University School of Medicine
-
Hirokazu FURUYA
Department of Neurology, Neuro-Muscular Center, National Oomuta Hospital
-
Yukitoshi TAKAHASHI
Shizuoka Institute of Epilepsy and Neurological Disorders, National Epilepsy Center
-
Hiroko IKEDA
Shizuoka Institute of Epilepsy and Neurological Disorders, National Epilepsy Center
-
Masaaki MURAMATSU
Molecular Epidemiology, Medical Research Institute, Tokyo Medical and Dental University
-
Mayumi UETA
Department of Ophthalmology, Kyoto Prefectural University of Medicine
-
Chie SOTOZONO
Department of Ophthalmology, Kyoto Prefectural University of Medicine
-
Shigeru KINOSHITA
Department of Ophthalmology, Kyoto Prefectural University of Medicine
-
Zenro IKEZAWA
Department of Environmental Immunodermatology, Yokohama City University Graduate School of Medicine